Gland Pharma gains over 2%
Thu, Jan 16, 2025 2:30 PM

Gland Pharma gains over 2%

A Flip by Swapnil Tiwari
Get it on Google Play
Shares of Gland Pharma gained 2% in intraday trading on January 16, 2025, after the pharmaceutical company said it received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for an inspection conducted at the Dundigal facility in Hyderabad. The inspection was conducted by the health regulator between July 22, 2024, and July 25, 2024.

More great flips

Post Office FD vs RD: Which will generate higher returns

Post Office FD vs RD: Which will generate higher returns

Post Office Fixed Deposit (FD) and Post Office Recurring Deposit (RD) are popular investment options for those who are looking for risk-free returns. These schemes are not linked to the market, so the returns are guaranteed. In FD, one can invest a lump sum amount at once, while in RD, investors can invest money every month. 

Open Flip
Kabra Jewels IPO sees 34 times subscription on second day of bidding

Kabra Jewels IPO sees 34 times subscription on second day of bidding

Jewellery retailer Kabra Jewels' initial public offering recorded more than 34 times subscription on January 16, the second day of bidding. The issue will close on January 17. The Ahmedabad-based firm approached capital markets to raise Rs 40 crore through maiden public issue of 31.25 lakh shares at the upper price band.

Open Flip
Infosys adds 5,591 employees in Q3

Infosys adds 5,591 employees in Q3

IT services giant Infosys' headcount increased by 5,591 in the third quarter ended December 31. This is the second consecutive quarter of net employee addition, reversing the previous trend of six quarters of headcount decline. This comes at a time when the company has started opening up hiring across levels, including freshers.

Open Flip

Join our Smart Investment Community

More than 2 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon